Key result
Chicken collagen hydrolysate reduces pulse wave velocity and blood pressure vs placebo over 18 weeks.
Why the study?
The effects of chicken collagen hydrolysate on the human circulation system in subjects with mild hypertension or high-normal blood pressure were not well established.
RCT (n=58)
We investigated the effects of a chicken collagen hydrolysate (CCH) on the circulation system in humans. A total of 58 subjects with either mild hypertension (systolic blood pressure (SBP) of 140-159 mmHg or diastolic blood pressure (DBP) 90-99 mmHg) or high-normal blood pressure (SBP 130-139 mmHg or DBP 85-89 mmHg) were assigned to two groups, one involving a placebo and the other, the test food (including CCH of 2.9 g/d). The parameters related to each subject's circulation system were monitored over the study period of 18 weeks. The Δbrachial-ankle pulse wave velocity (baPWV), an indicator of arterial stiffness and marker of vascular damage, was significantly lower in the test food group than in the placebo group during the treatment period. The blood pressure in the test food group was also significantly lower than that in the placebo group, while the serum nitrogen oxide was higher in the test food group after the treatment. These results suggest that CCH exerted modulatory effects on the human circulation system.
No takes yet. Share an insight, caveat, or question.
Kouguchi et al. (2013) conducted an RCT in Mild hypertension or high-normal blood pressure (n=58). Chicken collagen hydrolysate (CCH) vs. Placebo was evaluated on Change in brachial-ankle pulse wave velocity (ΔbaPWV). Chicken collagen hydrolysate (2.9 g/d) significantly reduced brachial-ankle pulse wave velocity and blood pressure compared to placebo over 18 weeks.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: